Evaluation of the Effectiveness of a Physical Activity Program on the Severity of Narcolepsy
NARCOSPORT
1 other identifier
observational
30
1 country
1
Brief Summary
Narcolepsy Type 1 (NT1) is a rare chronic neurological disorder resulting from the selective loss of hypocretin neurons. Patients with NT1 suffer from excessive daytime sleepiness, disrupted nighttime sleep, and cataplexy (emotionally triggered episodes of muscle atonia). The disease is associated with numerous comorbidities such as obesity, metabolic disorders, anxiety-depressive disorders, and attentional disorders, all of which have a strong impact on quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedStudy Start
First participant enrolled
August 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 24, 2023
CompletedJanuary 10, 2024
January 1, 2024
1.2 years
May 23, 2022
January 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline Narcolepsy Severity Scale (NSS) Score after training period.
The Narcolepsy Severity Scale is a validated scale exploring the different symptoms of NT1
before and after 6 weeks of physical activity program (training period)
Secondary Outcomes (12)
Narcolepsy Severity Scale (NSS) Score
At 6 months
Compliance with the training program.
weekly during the training period (up to 6 weeks)
Hospital and Anxiety Depression Scale score
At inclusion, at the end of the training program (6 weeks) and at 6 months
Frequency of cataplexy
every week during de training period (6 weeks)
Bron/Lyon Attention Stability Test (BLAST) score
Parameters will be measured at inclusion, at the end of the training program (6 weeks)
- +7 more secondary outcomes
Study Arms (2)
Immediate treatment (IT)
Patients randomized to the IT group will begin the training sessions 14 days after the inclusion.
Waiting list (WL)
Patients randomized to the WL group will receive a weekly phone call for 6 weeks. Then, they will benefit the same training program as IT group (56 days after the inclusion).
Interventions
The physical activity training program will consist of 3 sessions per week for 6 weeks : * 1 session will take place in the Sports Medicine Department of the Croix Rousse Hospital * 2 sessions will take place remotely. They will be led by an educator in Adapted Physical Activity in live video-conference.
Patients included in the WL group will receive a weekly phone call for 6 weeks (waiting period), before starting the physical activity training program described above.
After the training program, patients of both groups will be given a personalized training plan to be followed for 4 months with regular phone call from the Adapted Physical Activity educator.
Eligibility Criteria
Adult patients with type 1 narcolepsy, sedentary, aged 18 to 65 years. The patients will be recruited from the active file of adult NT1 patients followed in the Sleep Center of the University Hospital of Lyon.
You may qualify if:
- Diagnosis of Narcolepsy type 1 according to International Classification of Sleep Disorders, 3rd edition (ICSD 3-2014) criteria
- Patients aged 18 to 65 years
- Patients beneficiaries of social security
- Signed consent to participate in the study
- Access to a video conferencing device (smartphone, tablet or computer)
You may not qualify if:
- \- Patients with a high level of physical activity on the Ricci and Gagnon Questionnaire (score \>35) and/or regular physical activity in clubs
- Treatments not stabilized for less than 3 months
- Cognitive disorders incompatible with the understanding and implementation of the program
- Medical contraindication to exercise training
- Patient working night shifts
- Unstable somatic or psychiatric pathology
- Severe untreated obstructive sleep apnea syndrome (apnea/hypopnea index \>30/h)
- Pregnancy in progress or breastfeeding
- Persons deprived of liberty by a judicial or administrative decision,
- Persons admitted to a health or social institution for purposes other than research
- Persons of full age who are subject to a legal protection measure or who are unable to express their consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de médecine du sommeil et des maladies respiratoires
Lyon, 69004, France
Related Publications (1)
Ricordeau F, Stauffer E, Putois B, Jaffiol A, Cheylus A, Pouilloux G, Gabriel K, Hoarau E, Bastuji H, Franco P, Herbillon V, Capelle T, Joubert F, Pradat P, Spiegel K, Peter-Derex L. Feasibility and efficacy of exercise training on sleep symptoms and comorbidities in narcolepsy type 1: a prospective interventional study. Sleep. 2026 Jan 13;49(1):zsaf272. doi: 10.1093/sleep/zsaf272.
PMID: 40928141DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laure PETER-DEREX, MD, PhD
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2022
First Posted
July 15, 2022
Study Start
August 26, 2022
Primary Completion
November 24, 2023
Study Completion
November 24, 2023
Last Updated
January 10, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share